Examkin

Soru

Zorluk: OrtaDiagnostic and Screening Test Performance

A clinical pathology committee is reviewing the performance characteristics of various diagnostic and screening tests used across different departments in a healthcare network. They are analyzing how shifting cutoff thresholds and changing testing populations impact the predictive values and error rates of these assays. Match each clinical scenario with the corresponding statistical consequence it produces.

  • Lowering the diagnostic cutoff threshold for a serum tumor marker to prioritize missing fewer cases.Increases the false-positive rate and decreases the positive predictive value.
  • Implementing a rapid diagnostic test in an emergency department during peak disease season instead of an asymptomatic screening fair.Increases the positive predictive value while sensitivity and specificity remain unchanged.
  • Raising the minimum required titer for a positive confirmatory serologic test to reduce unnecessary treatments.Increases the false-negative rate and decreases the false-positive rate.
  • Deploying a highly accurate genetic screening assay in a general population where the target disorder is exceedingly rare.Yields an extremely high negative predictive value but a very low positive predictive value.

Cevap

Threshold shifts directly inversely alter sensitivity and specificity (lowering increases sensitivity and false positives; raising increases specificity and false negatives). Prevalence shifts alter predictive values (higher prevalence increases PPV) without changing intrinsic test accuracy.
Diagnostic cutoff shifts create an inverse relationship between sensitivity and specificity. Lowering a threshold captures more disease (fewer false negatives) but incorrectly flags more healthy individuals (more false positives), dropping PPV. Raising a threshold requires stronger evidence of disease, reducing false positives but missing mild cases (more false negatives). Meanwhile, population prevalence directly determines predictive values without altering test characteristics; testing higher prevalence populations raises PPV, whereas testing extremely rare diseases yields very low PPV.

Adım Adım Çözüm

1
Analyze how altering the cutoff threshold impacts sensitivity and specificity.
Lowering the cutoff increases sensitivity but decreases specificity. Raising the cutoff increases specificity but decreases sensitivity.
Sensitivity and specificity are intrinsically linked in a trade-off relationship determined by the selected cutoff point.
2
Correlate changes in sensitivity and specificity to error rates.
Decreased specificity leads to a higher false-positive rate. Decreased sensitivity leads to a higher false-negative rate.
False positives and false negatives represent the incorrect classifications made by the test.
3
Evaluate how disease prevalence within the tested population alters predictive values.
Testing in a higher prevalence population increases Positive Predictive Value (PPV) and decreases Negative Predictive Value (NPV).
Predictive values are highly dependent on the baseline risk (prevalence) of the disease in the specific population being tested.
4
Identify the impact of extreme low prevalence on predictive values.
Extremely low prevalence causes true positives to be so rare that false positives dominate the positive test results, plummeting the PPV regardless of the test's specificity.
Mathematical constraints of Bayes' theorem dictate that as prevalence approaches zero, PPV also approaches zero.

Anahtar Kavram

Diagnostic test performance depends on both the selected threshold (which trades off sensitivity and specificity) and the population prevalence (which dictates positive and negative predictive values).
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Diagnostic and Screening Test Performance

Bu konudan daha fazla soru